Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
M CosentinoG Frigo

Abstract

Attitudes to adverse drug reaction (ADR) spontaneous reporting were investigated among all the National Health Service (NHS) doctors operating in the territory of the Area Health Authority n.1 of Varese (Italy), to assess their awareness of the reporting system and to identify reasons for under reporting. Three hundred and fifty doctors were sent questionnaires and 207 (59.1%) were returned completed. More than 77% of the responders stated to have noticed ADRs, which were mainly reported to the pharmaceutical manufacturers and, in a minority of cases, to the NHS. Fifty per cent did not report ADRs to anyone. Important factors for deciding to report were unusualness and severity of the reaction, and involvement of a new drug. The main reason for not reporting was the clinical negligibility of the reaction. There was little knowledge about the types of reactions to be preferentially reported and the purposes of ADR reporting systems. Nevertheless, nearly everyone asked for feed-back information about reported ADRs. NHS doctors in this district have little information concerning ADR reporting systems. Some effective measures to improve the situation could be: inclusion of pharmacovigilance into pre- and post-graduated continuing e...Continue Reading

References

Jul 1, 1988·British Journal of Clinical Pharmacology·M D Rawlins
Mar 1, 1995·British Journal of Clinical Pharmacology·K J BeltonS M Wood

❮ Previous
Next ❯

Citations

Jan 1, 2009·Pharmacy World & Science : PWS·Ghazal VessalMehri Mollai
Aug 11, 2011·American Journal of Pharmaceutical Education·Ramadan Mohamed ElkalmiMuhammad Abdul Hadi
Jan 1, 2013·American Journal of Pharmaceutical Education·Paul Gavaza, Bihn Bui
May 11, 2011·Journal of the American Pharmacists Association : JAPhA·Paul GavazaMary Steinhardt
Oct 2, 2012·Journal of the American Pharmacists Association : JAPhA·Paul GavazaJames P Wilson
Oct 2, 2012·Journal of the American Pharmacists Association : JAPhA·Paul GavazaJames P Wilson
Sep 16, 2008·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A ZancanL Manzo
Oct 16, 2004·Journal of Evaluation in Clinical Practice·María T HerdeiroAdolfo Figueiras
Dec 6, 2012·Pharmacoepidemiology and Drug Safety·Christelle CholPatrick Mismetti
Feb 22, 2011·British Journal of Clinical Pharmacology·Paul GavazaMary Steinhardt
Aug 23, 2005·Expert Opinion on Drug Safety·Manfred HaubenEugene P Van Puijenbroek
May 15, 2015·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Mohamed M M Abdel-Latif, Basel A Abdel-Wahab
Feb 25, 2015·Journal of Advanced Pharmaceutical Technology & Research·Het B UpadhyayaPruthvish B Patel
Jun 23, 2016·Journal of Basic and Clinical Pharmacy·Mohamed M M Abdel-Latif
Oct 23, 2014·Revista da Escola de Enfermagem da U S P·Fabiana Rossi VaralloPatricia de Carvalho Mastroianni
Jul 8, 2008·European Journal of Clinical Pharmacology·Y ZopfH Dormann
Apr 11, 2018·European Journal of Clinical Pharmacology·Xinling LiJielai Xia
Aug 10, 2006·European Journal of Clinical Pharmacology·Manfred HaubenVaishali K Patadia
Sep 2, 2006·Pharmacoepidemiology and Drug Safety·Zoriah AzizNurul Suhaida Badarudin
Oct 1, 2008·European Journal of Clinical Pharmacology·Elisabet Ekman, M Bäckström
Jan 10, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Elena Lopez-GonzalezAdolfo Figueiras
Jun 18, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Vincent NicholsJohanne Collin
Aug 27, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Maria T HerdeiroJuan Jesus Gestal-Otero
Jul 3, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Slobodan M JankovicSladjana Petrovic
Jul 17, 1999·Journal of Quality in Clinical Practice·R PortelliP Desmond
Jun 19, 2012·European Journal of Clinical Pharmacology·Chiara BiagiDomenico Motola
Nov 26, 2008·Pharmacoepidemiology and Drug Safety·UNKNOWN Adverse Drug Reaction and Medicine Review Committee
Aug 19, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Yurdaguel ZopfHarald Dormann
Aug 10, 2021·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sieta T de VriesUNKNOWN IMI Web-RADR Work Package 3b Consortium and SCOPE Joint Action Work Package 4

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.